Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
China's Farmland Acquisition: Strategic Concerns for US Military - Dr. Phil on Joe Rogan Experience
Nice post, georgejjl. Thanks for your research and please keep on posting.
Who knows. Maybe that new market won't allow naked short selling. Might be a good place to go.
Don't we already have that in NY? Maybe trying to branch out under new management. Lol.
Citadel Securities, BlackRock back Texas Stock Exchange in challenge to NYSE, Nasdaq
A new stock exchange! What's' up with this?
https://www.msn.com/en-us/money/companies/citadel-securities-blackrock-back-texas-stock-exchange-in-challenge-to-nyse-nasdaq/ar-BB1nGXAf?ocid=BingNewsSerp
George puts out great AVXL information. Keep them coming, George and thanks for your research.👏
Nice find georgejjl. At some point soon one or a few off the BP companies will have to make a move on A2-73 Blarcamazine. It's to big of a risk to miss out on. Blarcamazine has now made it to Neurology Live. It's no longer a sleeper.
I agree. Also: One of the most exciting aspects of blarcamesine is its potential therapeutic application in Alzheimer’s disease and other neurodegenerative disorders such as Parkinson’s. Preclinical studies have demonstrated that blarcamesine can mitigate cognitive decline and reduce pathological features associated with neurodegeneration. This includes the reduction of amyloid-beta plaques and tau protein tangles, hallmark indicators of Alzheimer's disease.
The 48-week open-label extension of its Phase 2 study, Anavex 2-73-PDD-EP-001 (NCT04575259), assessed the investigational agent Anavex 2-73, known as blarcamesine. The study demonstrated positive outcomes in meeting primary and secondary objectives within the target cohort. Anavex Life Sciences is a clinical-stage biopharmaceutical company specializing in therapies for neurodevelopmental and neurodegenerative disorders.
AVXL should have a $10 to $15 Billion MC with today's current drug trial results. imo
https://news.marketersmedia.com/anavex-life-sciences-corporation-release-a-phase-2-extension-study-report-of-parkinson-disease-dementia-showed-blarcamesine-to-be-safe-and-effective/89131553
Nice post georgejjl. "Anavex Life Sciences Corporation Release A Phase 2 Extension Study Report of Parkinson Disease Dementia Showed Blarcamesine to be Safe and Effective"
https://news.marketersmedia.com/anavex-life-sciences-corporation-release-a-phase-2-extension-study-report-of-parkinson-disease-dementia-showed-blarcamesine-to-be-safe-and-effective/89131553
You seem to be here every time I pass through. I thought you were a Monday through Friday person.
Pathetic. It’s truly sad.
That your working the weekends.
Rumer has it that he is looking into nefarious naked short selling activity along with several others.
BIO when you think off all the other CNS diseases it could treat, $12 Billion is cheap for a 3-71 partnership.
We could make a 3-71 partnership deal with BP for $12 billion.
Agree with this list except for Bourbon. Thanks for your support of AVXL. Best in class cutting edge CNS company. 👏
Inflation is still going up. Dollar is loosing value on a daily basis. That article you posted is probably written by Investor.
Agree. Imo. Fake Investor is thee primary instigator of the lawsuits.
Insider Financial. Great find, georgejjl..👏
Blackberry Smoke - Keep On Smiling (Live From Capricorn Sound Studios)
That's terrible. Sounds like you defiantly have some recourse their but I know that doesn't help your health issues. We need to get 2-73 approved ASAP so you can help restore your mitochondria. Their has to be a way to access the drug through compassionate use.
Anyone know of a way to access A2-73 through compassionate use?
Spot on, Xena. They support companies with black box warnings on their drugs that actually hurt or even kill the patient. Right now the retail investor has lost their protection against the corrupt market. Hope they can get it turned around. imo
It's hard to believe that you don't see the corrupt manipulation on the company and to the stock price.
$100 per share or $8 Billion MC is a cheap price with current drug trial results we know today. imo. Incredible...
I agree. I would much rather have every 6 hr. dosing. No side effects. Sleep great.
Nice find, georgejjl 👏
"The results show a statistically significant deceleration in cognitive decline associated with Alzheimer's, marking a pivotal advancement in the pursuit of effective treatments for this debilitating condition using blarcamesine or Anavex 2-73."
https://www.sciencetimes.com/amp/articles/50071/20240508/anavex-life-sciences-alzheimers-treatment-brings-hope-to-millions.htm
ignatiusrielly35. Thank you for your reply. I am always learning how things work in this wonderful age of AI digital control. It's good for people to see the market they are investing in.
Broken Arrow.
Thanks ignatiusrielly35 for your market savvy.
ignatiusrielly35 - What about AVXL hiring a stock transaction auditor? Let's see who are transacting in stock activity and where the shares going? This should show who's naked shorting the stock. We can take the results to congress if the SEC doesn't act on it.
You never answered the question from ihidffromthex
How many drugs are out there that reduce brain atrophy?
"Let's not forget there is no brain swelling, bleeding or dying from taking Blarcamesine.
That has to be worth something, right?"
Absolutely! No brain bleeding or death over here. Blarcamesine, A2-73 should be a winner in the CNS disease slam dunk competition. :)
That right their is worth a $15 Billion MC.
"Let's not forget there is no brain swelling, bleeding or dying from taking Blarcamesine.
That has to be worth something, right?"
Absolutely! No brain bleeding or death over here. Blarcamesine, A2-73 should be a winner in the CNS disease slam dunk competition. :)
"The obsession on this message board for attacking Anavex and Dr. Missling is notable and misplaced."
Correct. It's " Hey look over here at thee CEO" while the paid bashers block for and support the neked shorting program.
Retail investors have lost their investment protection. imo
tradeherpete - "What Dr. would have a problem prescribing a safe drug to a CNS patient that will slow their brain shrinkage?"
Yes. Fully agree. I tagged a $15 billion MC price because it's obvious what kind of break through therapy this is. Your right. You can't really put a price on this when everyone after 49 years old needs to preserve their brain from shrinking. Lol. Oh My...
That right there is worth a $15 billion Market Cap.
He has been the lead idiot from the beginning.
Nope.. Need a $15 billion MC. Then you have a deal for a Company worth $30 billion. Smokin deal only for you.
Yea. It's ridiculous how much money they have taken out of this company. Best in class cutting edge CNS company on the market trading at a MC of $300 million.
Yea, you can't win because it's corrupt and the retail investor no longer has any protection.
Your right. They naked short sell the stock and steal from the company value and at the same time billionaire is paying these bashers saying " Hey look over here at the CEO" while in fact they are assisting, robbing the company value. SEC is shett..No protection for the retail investor. Whole market is Fubar corrupt.imo
Agree. It looks like the retail investor has lost its protection against criminal shorting practices.
Phoenix64 - Their is nothing wrong with Dr. Misslings presentation. He actually had a very good presentation. IMO, Anavex has a block buster drug in A2-73 and A3-71 that our competitor's are scared to death of. These drugs beat the current SOC in the CNS space hands down. You can see how the opposition lies about results. The people who are taking these drugs are getting better without any side effects unlike other CNS drugs. The criminal syndicate attack our stock every time Missling speaks to discourage investors. Imo.